Single-plasmid double-sgRNA gene knockout kit and application thereof

By using single plasmid double sgRNA in the CRISPR/Cas9 system to achieve gene knockout, the problems of gene editing uncertainty and detection difficulty are solved, the reliability and efficiency of large fragment gene knockout are achieved, and the detection process is simplified.

CN118995818AInactive Publication Date: 2024-11-22YUANJIAN BIOTECH SHANGHAI CO LTD

Patent Information

Application Number
CN202411408808.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-10
Publication Date
2024-11-22
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The CRISPR/Cas9 gene editing system has uncertainty and difficulty in detection during gene knockout, especially the uncertainty of insertion or deletion introduced by a single sgRNA, and the existing detection methods are costly and inefficient.

Method used

The single plasmid double sgRNA knockout kit is used to express two sgRNAs simultaneously in one plasmid to ensure that all bases between the target sequences are deleted, thereby achieving large fragment gene knockout and direct detection by PCR and electrophoresis. Simplified the distinction between knockout and wild type.

Benefits of technology

The uncertainty of a single sgRNA protocol is eliminated, the reliability and efficiency of gene knockout is ensured, and it is suitable for large-scale screening, reducing detection costs and time.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118995818A_ABST
    Figure CN118995818A_ABST
Patent Text Reader

Abstract

The invention relates to a single-plasmid double-sgRNA gene knockout kit and application thereof.The single-plasmid double-sgRNA gene knockout kit comprises a first proplasmids and a second proplasmids, the first proplasmids and the second proplasmids are subjected to enzyme digestion connection to obtain gene knockout plasmids, the gene knockout plasmids contain two sgRNAs and Cas9 protein expression cassettes, and the sgRNAs and the Cas9 protein expression cassettes are separated from each other to obtain the single-plasmid double-sgRNA gene knockout kit. The sgRNA comprises a first sgRNA and a second sgRNA. According to the invention, two sgRNAs are simultaneously expressed in one plasmid, which is different from the introduction of individual base insertion or deletion when only one sgRNA exists, and the two sgRNAs can cause the deletion of all bases between target sequences, so that the method is more suitable for constructing large fragment deletion type gene knockout.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of genetic engineering, and in particular to a single-plasmid double-sgRNA gene knockout kit and applications thereof. Background Art

[0002] CRISPR / Cas9 technology is the most commonly used gene editing system. It is a technology that uses RNA to guide Cas9 nuclease to perform specific DNA modifications on targeted genes. The gene expressing Cas9 protein and transcription gRNA is connected to the plasmid, and the plasmid is transfected into the target cell to express Cas9 protein and gRNA. The sgRNA guides the Cas9 protein to cut at the target sequence. This cutting will cause the introduction of 1 to 2 base insertions or deletions near the incision, thereby causing the gene's readable frame to shift and achieve gene knockout.

[0003] However, this system has two major defects: (1) In addition to the insertion or deletion of 1 to 2 bases near the incision, the insertion or deletion of 3 bases can also occur. The insertion and deletion of 3 bases will not cause the gene reading frame to shift, but will only increase or decrease 1 to 2 amino acids, and may not even affect the function of the gene. In other words, there is a certain uncertainty in using this system to achieve gene knockout. (2) The sequence of the CRISPR / Cas9 gene after knockout is only a few bases different from the wild type. There are usually two detection methods: (a) Enzyme digestion: that is, the sample to be tested is annealed and hybridized with the wild type, and then the endonuclease is cut and electrophoresed for detection. If the sample to be tested is a knockout type, two to three bands will appear after enzyme digestion, otherwise only one band will appear. Affected by many factors such as sample preparation, annealing and hybridization, enzyme digestion efficiency, and electrophoresis technology, the brightness of the bands produced by the knockout type is usually weak, and the knockout type is easily misjudged as the wild type. Therefore, this detection method has high requirements for experimental conditions and technology. (b) Sequencing: After the target region is amplified, the sample is sequenced by Sanger sequencing. This method can accurately determine the genotype of the sample. However, this method is expensive, especially when a large number of samples need to be screened, the cost and time are much higher than the previous detection method.

[0004] CN110468133A discloses a method for knocking out the pig GOT1 gene using the CRISPR / Cas9 system, discloses an sgRNA specifically targeting the pig GOT1 gene, a CRISPR / Cas9 gene knockout vector containing the sgRNA, a method for knocking out the pig GOT1 gene using the vector, and a method for detecting the pig GOT1 gene. The disclosed CRISPR / Cas9 knockout vector can achieve a high knockout efficiency of the pig GOT1 gene, significantly improves the construction efficiency of GOT1 gene knockout cells and GOT1 gene knockout pigs, and provides an effective method and basis for the functional research and application of the pig GOT1 gene.

[0005] CN112941077A discloses a CRISPR / Cas9 system for targeted knockout of the GLK gene and its application. Specifically, the GLK gene of birch is used as the editing target gene, and the ribonucleoprotein complex RNP obtained by mixing the in vitro purified Cas9 protein with GLK-gRNA is bombarded with the birch callus tissue through microparticles to preliminarily establish a gene editing technology without T-DNA insertion, and the gene editing technology is used to obtain birch yellow leaf plants.

[0006] In summary, how to improve the efficiency of CRISPR / Cas9 gene editing has become one of the urgent problems to be solved in this field. Summary of the invention

[0007] In order to solve the above technical problems, the present invention provides a single-plasmid dual-sgRNA gene knockout kit and its application. The present invention simultaneously expresses two sgRNAs in one plasmid. Different from introducing individual base insertions or deletions when there is only one sgRNA, the two sgRNAs will cause all bases between the target sequences to be deleted, which is more suitable for constructing large-fragment deletion-type gene knockouts.

[0008] To achieve this object, the present invention adopts the following technical solutions:

[0009] In a first aspect, the present invention provides a single-plasmid dual-sgRNA gene knockout kit, which comprises a first precursor plasmid and a second precursor plasmid, wherein the first precursor plasmid and the second precursor plasmid are enzymatically cut and connected to obtain a gene knockout plasmid, wherein the gene knockout plasmid contains two sgRNAs and a Cas9 protein expression frame, and the sgRNA comprises a first sgRNA and a second sgRNA.

[0010] The gene knockout plasmid used in the present invention can simultaneously express two sgRNAs and Cas9 proteins, including all components required for gene knockout, and only one plasmid can achieve the knockout of dual-target target genes.

[0011] Preferably, the first precursor plasmid contains a gRNA scaffold and a U6 promoter, the upstream of the gRNA scaffold contains a first restriction site, and the downstream of the U6 promoter contains a second restriction site.

[0012] Preferably, the first precursor plasmid (pXsg3) used in the present invention has a structure such as Figure 1 shown.

[0013] Preferably, the second precursor plasmid contains a U6 promoter, a gRNA scaffold and a Cas9 protein expression frame, the downstream of the U6 promoter contains a third restriction site, and the upstream of the gRNA scaffold contains a fourth restriction site.

[0014] Preferably, the second precursor plasmid (pXsg6) used in the present invention has a structure such as Figure 2 shown.

[0015] The two precursor plasmids used in the present invention do not contain gene-specific sgRNA sequences, and therefore can be replicated individually and reused multiple times.

[0016] Preferably, the first restriction enzyme cutting site, the second restriction enzyme cutting site, the third restriction enzyme cutting site and the fourth restriction enzyme cutting site are each independently a restriction enzyme cutting site of any one of BsaⅠ, EcoRI, XhoI or BamHI.

[0017] Preferably, the first restriction enzyme cutting site is the same as the third restriction enzyme cutting site, and the second restriction enzyme cutting site is the same as the fourth restriction enzyme cutting site.

[0018] Preferably, the first restriction enzyme cutting site, the second restriction enzyme cutting site, the third restriction enzyme cutting site and the fourth restriction enzyme cutting site are the same.

[0019] The present invention further optimizes the structure of the precursor plasmid, and can uniformly use one endonuclease to digest the two plasmids, thereby simplifying the operation steps. Only one endonuclease and one ligase are used in the entire scheme to construct a double sgRNA knockout plasmid for gene knockout.

[0020] Preferably, the first precursor plasmid contains a replication origin, a gRNA scaffold, a U6 promoter, a resistance gene promoter and a resistance gene along the replication direction, a first restriction site is contained between the replication origin and the gRNA scaffold, and a second restriction site is contained between the U6 promoter and the resistance gene promoter.

[0021] Preferably, the second precursor plasmid contains a replication origin, a U6 promoter, a gRNA scaffold, a Cas9 protein expression frame, a resistance gene promoter and a resistance gene along the replication direction, and contains a third restriction site and a fourth restriction site between the U6 promoter and the gRNA scaffold.

[0022] Preferably, the gene knockout plasmid is prepared by the following preparation method:

[0023] (1) digesting the first precursor plasmid and the second precursor plasmid with restriction endonucleases, respectively, and recovering the digestion products of the first precursor plasmid small fragment and the second precursor plasmid large fragment;

[0024] (2) Synthesize sgRNA primers and anneal;

[0025] (3) T4 DNA ligase is used to connect the products of step (1) and step (2) to obtain a gene knockout plasmid.

[0026] The present invention can use the same restriction endonuclease to digest the first precursor plasmid and the second precursor plasmid, and connect them with sgRNA through T4 DNA ligase to construct a knockout plasmid at one time. The method for constructing a knockout plasmid provided by the present invention requires digestion of the vector and connection with T4 DNA ligase, which is the same as the workload of traditional construction of a knockout plasmid, while the present invention can load two sgRNAs at one time, which is faster and more efficient.

[0027] After the first precursor plasmid of the present invention is digested with a restriction endonuclease, a smaller fragment containing a gRNA scaffold and a U6 promoter and a larger fragment containing a resistance gene promoter, a resistance gene and a replication origin are obtained, and the smaller fragment is recovered; after the second precursor plasmid of the present invention is digested with a restriction endonuclease, a larger fragment containing a gRNA scaffold, a Cas9 protein expression frame, a resistance gene promoter, a resistance gene, a replication origin and a U6 promoter and a smaller fragment between the third restriction site and the fourth restriction site are obtained; and the two fragments are connected by T4 DNA ligase to obtain a gene knockout plasmid containing two sgRNAs and a Cas9 protein expression frame.

[0028] Preferably, the gene knockout plasmid contains a replication origin, a U6 promoter, a first sgRNA, a gRNA scaffold, a U6 promoter, a second sgRNA, a gRNA scaffold and a Cas9 protein expression frame along the replication direction.

[0029] Preferably, the gene knockout plasmid (pXsg-Dual) used in the present invention has a structure such as Figure 3 shown.

[0030] Preferably, the nucleic acid sequence of the sgRNA includes the sequence shown in SEQ ID NO.1 to SEQ ID NO.6.

[0031] SEQ ID NO. 1: GCTCTAAAAGCCCCACTATCT.

[0032] SEQ ID NO. 2: GAGATGTTGGCTAGAACTGAG.

[0033] SEQ ID NO. 3: TATATACTTGGTACAGCCCT.

[0034] SEQ ID NO. 4: TAGAGGAATTATGTCAGGTA.

[0035] SEQ ID NO. 5: TCTGCCCTCCATTGCTGGTT.

[0036] SEQ ID NO. 6: CTACATGGGGAAATCAACTA.

[0037] The sequence of the sgRNA of the present invention can be designed according to the gene to be knocked out and the site to be knocked out, and is not limited to the sequences shown in SEQ ID NO.1 to SEQ ID NO.6 listed above.

[0038] Preferably, the gene knockout kit further comprises a restriction endonuclease.

[0039] In a second aspect, the present invention provides use of the single-plasmid dual-sgRNA gene knockout kit as described in the first aspect in gene knockout.

[0040] The single-plasmid dual-sgRNA gene knockout system provided by the present invention has broad application prospects and can be applied to fields such as biological research on constructing gene knockout animal models and improving plant traits through gene knockout.

[0041] Preferably, the application includes application of the single-plasmid dual-sgRNA gene knockout system in animal gene knockout.

[0042] Preferably, the gene includes any one of MCM8, HELQ or HUWE1.

[0043] In a third aspect, the present invention provides a method for dual-target CRISPR / Cas9 gene knockout, the method comprising knocking out a gene using the single-plasmid dual-sgRNA gene knockout kit described in the first aspect.

[0044] Preferably, the method specifically comprises: enzymatically ligating the first precursor plasmid and the second precursor plasmid in the single-plasmid dual-sgRNA gene knockout kit to obtain a gene knockout plasmid, introducing the gene knockout plasmid into cells, screening cells with gene editing effects, and verifying the gene knockout effect by molecular biological methods.

[0045] The single-plasmid dual-sgRNA gene knockout system used in the present invention is more suitable for large-fragment gene knockout, can be quickly identified by agarose gel electrophoresis, and is suitable for large-scale screening.

[0046] Compared with the prior art, the present invention has the following beneficial effects:

[0047] (1) The present invention simultaneously expresses two sgRNAs in one plasmid. Unlike the introduction of individual base insertions or deletions when there is only one sgRNA, two sgRNAs will cause all bases between the target sequences to be deleted. Therefore, based on the different working methods, the present invention eliminates the uncertainty of knockout using only one sgRNA scheme, and can ensure gene knockout. It is more suitable for constructing large-fragment deletion-type gene knockouts, and the number of deleted bases can be greater than 1000bp. The most important functional domains or structural domains of the gene can be designed within the deletion range, adding another insurance to gene knockout.

[0048] (2) The present invention does not require complicated annealing and enzyme digestion during knockout detection. Since the size of the knockout fragment is approximately the number of bases between sgRNAs, the knockout type and the wild type can be directly amplified into PCR products of different sizes, which can be detected by direct electrophoresis, and are suitable for large-scale screening. BRIEF DESCRIPTION OF THE DRAWINGS

[0049] Figure 1 is a structural diagram of plasmid pXsg3;

[0050] Figure 2 is a structural diagram of plasmid pXsg6;

[0051] Figure 3 is the structure diagram of plasmid pXsg-Dual;

[0052] Figure 4 This is a diagram of the sequencing results of gene knockout in Example 1;

[0053] Figure 5 This is a diagram of the sequencing results of gene knockout in Example 2;

[0054] Figure 6 This is a diagram of the sequencing results of gene knockout in Example 3. DETAILED DESCRIPTION

[0055] To further illustrate the technical means and effects of the present invention, the present invention is further described below in conjunction with the embodiments and drawings. It should be understood that the specific implementation methods described herein are only used to explain the present invention, rather than to limit the present invention.

[0056] If no specific techniques or conditions are specified in the examples, the techniques or conditions described in the literature in the field or the product instructions are used. If no manufacturer is specified for the reagents or instruments used, they are all conventional products that can be purchased through regular channels.

[0057] Preparation Example 1

[0058] This preparation example prepared a gene knockout plasmid, including the following steps:

[0059] (1) Plasmid pXsg3 and plasmid pXsg6 were digested with BsaⅠ, and the digestion product of about 500 bp of plasmid pXsg3 and about 8000 bp of plasmid pXsg6 were recovered;

[0060] (2) Synthesize sgRNA primers and anneal;

[0061] (3) T4 DNA ligase is used to connect the products of step (1) and step (2) to obtain a gene knockout plasmid, wherein the nucleic acid sequence of sgRNA is shown in SEQ ID NO.1 to SEQ ID NO.2.

[0062] Preparation Example 2

[0063] This preparation example prepared a gene knockout plasmid, which differed from Preparation Example 1 only in that the nucleic acid sequence of sgRNA was shown in SEQ ID NO.3 to SEQ ID NO.4.

[0064] Preparation Example 3

[0065] This preparation example prepared a gene knockout plasmid, which differed from Preparation Example 1 only in that the nucleic acid sequence of sgRNA was shown in SEQ ID NO.5 to SEQ ID NO.6.

[0066] Example 1

[0067] In this example, the gene knockout plasmid prepared in Preparation Example 1 was used to knock out the MCM8 gene in animal cells. The transcript number was NM_032485.6, and the partial gene sequence was shown in SEQ ID NO.7, wherein the underlined portion was the sgRNA target, and the italicized portion was the base deleted after gene editing.

[0068] SEQ ID NO.7:ggtgcagggaactgtcttttttgtgctgttaaaatacccatttgtttcttatgtctcatgaggggtgtgtgtgtgtgtgt gtgtgtgtgtgtgtgtgcatactttttatttttttttgagatggagtcttgctctgttgcccaggctgaagtgcagtggcgcgatcttggctcactgcaagctctgcctcccaggttcacgccattctcctgcctcagcctcccgagtagctgggactacaggcacccgccaccacgcccggctaattttttctgtttttagtagagacggggtttcaccgtgttagctaggatggtcttgatctcctgacctcgttatccgcccgcctcggcctcccaaagtgctaggattccagacgtgagccaccgcacccagccgcatactttttttttttaggaaaactagacgtttgaggtccaggaccctccctgccccataccaggcatgcagtagtcattttgtgaatgaatagagtactttacaaatgttttctttattggaaatctgttcgtttttttccatcaatagaatctgtttcatgaatgatcttttgttcctttaggatgtattagccaccagcactcccattgctcccctagcagatagctcagaacactataagtgatctttggacagtcctaaagatggagttcaagaggtgccttagccttcaccatctgtgcttccaaactactttattgtactgttcttctgtgagagacatatttgaaaatgtagaactttagagtgttaaaaaaaaaaaggcttttcagttttgccaccagggtcaagtgttggtctgtctcctgatctcaggaaagactgtgattgtgattgtcttcagctctgtcagagtaagagcttagtttatgtgtctggctttggctttattataatttttagtttaagcttattgtctaaattatctgaactaacatgtcctattaggtgtcaaagatgcaaaacaaagtttccc. agatagtggggcttttagagagagagagtttctgtctgcatttcacattatgcaaacctaaatttgttttagaatcttaagtttacattctatactagttcttatatgaatgtaatcaaaatacaaagcaattagaaaaaaatcatctaccatgtatatagtgctgcttttgtctcatgaaaaatgtgcatgtacctgtgtgattatttgtgctaatgccatatttgttggattagtttacagcgatagctctcctttgattgagaagattcaagcatttgaaaaatttttcacaaggcatattgatttgtatgacaaggtaagattcctctacagcaaagctaccagtcatgtgccatcttaccaatgtattcgaggtacttgtgattatgatcgtaggcactggagtcagacttccttggttcagacctcagttctgccacttacctgcagtatggactttgattaattacttctctgtgcctcagttttctttcatttggagatagaggtataaatacctacctcaaaggattgttaagaggcagtaatacattaatatatttaaaatatcagaaccatgcttggcacaaagcttatacttatgtcatacttaccattatcacatataaacattgtatgctttctcaaagtctataatagaatgctcagttaatggtaattgactacagaaaagcaattattgttttcatacttttatattttataggatgaaatagaaagaaagggaagtattttggtagattttaaagaactgacagaaggtggtgaagtaactaacttgataccagatatagcaactgaactaagagatgcacctgagaaaaccttggcttgcatgggtttggcaatacatcaggtaactatttgtcttatgcatacttttgtctaaacttttttaatgtttgcacacacatgcacaccttgtctaagtttaaaggaagattttacagtgactgtactttctataagagatacttagcttttacgaaa agatgttggctagaactgagaggttgcagttccgttctgaaagataccattcattctatatacaacagcttatctaaatgaaatatttacctccaacttatttggatttgcttaatcttgctaaagattgtgcagaaattaaactttgctttcaagaagttatacaatctcatagggaagataaaacaaggaatcatggtgttatcggttatgaacttagagcaaaaaagagcaaccttagatttaggttctgtggcatgaagcaaaccactgagtgtccctgtatatcaaatgtaaataacagtttgtactgtgcttgcctgagttttttttcagggtcaggtaatacaacatatatgaaaacatttttaactttttaaattttttaaatttattttttatttatttttttgagatggagtttcactttgttgccaggctggagtgcagtgtcatgatctccgctcactgcaacctctgcctcccgggttcaagtgattctcttgcctcagcctcccgagtggctgggtgcaccaccatgcccagctaagttttggagttttagtagagacggggtttcacgatgttggccaggatggtcttgatctcttgatcttgtgatccgcctgccttggcttcctaaagtgctaggattacaggcatgagccaccttgcccggccaaaaacattttttaggctagcaaacagatacatgcttcaaggtaatgaatagcaaatctcaggacaggcatacacaaagtgctggggcattcagaggggcattcttctacctcttgcctgtgctgtccattcaacatagaatccccttcccttcacatggacagattatttgggcctagctcagttgtctgtctgtaaaacctttctcatgaccacttttcgaaacttgcatggtattttgtctgtacatctttatggtccttatgacaattacagctgtatatatgcatcttattttgcctcttaggttgccagcaaactgctgtgtacaagtg。

[0069] The sequencing results are as follows Figure 4 As shown, the target gene produces a 1027 bp deletion, which appears at position 180: GTTTCCCAGA / deletion / TGAGAGGTTG, including exons 3 and 4 of the target gene, resulting in a 233-base deletion in the coding region, expressed as c.254_486del:p.V85GfsX4, achieving gene knockout.

[0070] Example 2

[0071] In this example, the gene knockout plasmid prepared in Preparation Example 2 was used to knock out the HELQ gene in animal cells. The transcript number was NM_133636.5, and the partial gene sequence was shown in SEQ ID NO.8, wherein the underlined portion was the sgRNA target, and the italicized portion was the base deleted after gene editing.

[0072] SEQ ID NO.8: tgttttagtacagctttaagaattacaatctggccgtgtgcagtggctcatgcctataatcccagtgctttaggagg cagagatgggaggatcacttaagcccagaagttcgcgttcaaaaccagcctaggcaacagagacccagtctctacaaaaaaaaaaaaaaatttttttttct taattagccgggtgtggtggcctgcacctgtagtcctagctacttgggaggctgaggcaggaggatcgcttgagcccaggatgtcaagactgcagtgagctg tgatcgtgcagtggctggagccactgtgctccagcctgggtgacagagccagaccctgtctcaaaaattagaatctcagtatcatcgtaacactcctgaac ctgctgtttaggcaagtaatttaacctctttgggcctccatttcttcagctgtaagatatctatttacatataggtctgtgatccatatgtgaccatataat tatatacttggtacagccct tacctgacataattcctcta attcctcatctataagaaagggataataagttgttagcaagtcagattctggttcaaagacatgccaaaattcaatgttggtaatgattttcaataattatattggtagcttctaagtaaga actttagtaaattaccccactctaattctgggttctgtgctctcattctctcacttaagatctgatgactgagacgtctaaacacagtgttacttttaatgtttaccttacctgacttctc aataacttacctgatgctattgactacacccttcttgaaattcttgtttctggatgtccttacaaccactcctgttttttgaccccgattgtctagtagagatcctcagctttcttagttg tatttccttggctggctctgtcttctctaccaaaacctagctgttgtggtatgtctttgacactcacatgtcttgagtgaaagaagtcagttattagtaatactgttgattaaaccaaac.

[0073] The sequencing results are as follows Figure 5 As shown, the target gene produced a 1259 bp deletion, which appeared at position 612: TTGGTACAGC / deletion / CTGACATAAT, including the second exon of the target gene, resulting in a deletion of 715 bases in the coding region, expressed as c.298_1012del:p.P100NfsX6, achieving gene knockout.

[0074] Example 3

[0075] In this example, the gene knockout plasmid prepared in Preparation Example 3 was used to knock out the HUWE1 gene in animal cells. The transcript number was NM_031407.7, and the partial gene sequence was shown in SEQ ID NO.9, wherein the underlined portion was the sgRNA target site, and the italicized portion was the base deleted after gene editing.

[0076] SEQ ID NO.9:tcttttatgtgtactcatatctagcatgatttctggcatgttagtgggtgctcaggaaatctttgttgaaaactaaatg aatatgcctaaatcccattagtttatgcttcagggtactgtgtccggtattaacctcatcgtggaattcattgaatgtgaattacacacattctgaagttttactacagtgtcacacaaatttctgacttactctgcaatggtccataaattctgttctttacaaagtgtttacagtaaaagcagaagcataggaagaggctaaaatggaaatcttatattgaaggcatagtggagttacatcaagtagtaatgttatgaaaaattaactcagagcttttcctatttccatccccaaaattctttctcaaagactaataatacctttagtagtggaatctgtcaattcagtgtctgtttagagattatcagttgtatttgatccagtccttcagaatttaatttggtgatgat tctgccctccattgctggtt ctacatggggaaatcaacta agggtgtagagatgcaagtttggggtgtttcacagtgagggcaaataatataagaaagctttatccagaaaaagttatacttaagtagaaggccagtttggctttctagttatctaattaacaat gtttaagagcagctacttccattattgagacttttatcatagtgtagaatggtcaggaggtcatgggttctggttaaaacattgccacatgttatcatgcctttacacaaccatagggaaaatat atgtcagggtactttgtaagttgtgttgtagtagtaatagcctttactatgtgcagggcaatgagcaccagctttttctccctaaatatcttacttaatcctgcaaagtaattgatgtccccat tacctcagaggttgagtcgcagaagtcatagaactgtcatttggcaggcaccaaaaataaaacacatgttttcccccatactgtgctgccttactgaggccccagactacatgtatacaaaagc.

[0077] The sequencing results are as follows Figure 6 As shown, the target gene produced a 1289 bp deletion, which appeared at position 363: TCTGCCCTCC / deletion / TAAGGGTGTA, including exons 13, 14, and 15 of the target gene, resulting in a deletion of 380 bases in the coding region, expressed as c.863_1242del:p.V288GfsX7, achieving gene knockout.

[0078] Comparative Example 1

[0079] In this comparative example, two CRISPR / Cas9 gene knockout plasmids were prepared, each of which carried an sgRNA expression frame and a Cas9 expression frame, and the nucleic acid sequence of the sgRNA was shown in SEQ ID NO.1 to SEQ ID NO.2, to knock out the MCM8 gene of animal cells. However, this method can only be achieved when both plasmids are transferred into cells at the same time, and the double plasmid transfection efficiency is low.

[0080] In summary, the present invention provides a single-plasmid dual-sgRNA gene knockout kit, which simultaneously expresses two sgRNAs in one plasmid. Different from the introduction of individual base insertions or deletions when there is only one sgRNA, two sgRNAs will cause the deletion of all bases between the target sequences, which is more suitable for constructing large-fragment deletion-type gene knockouts, eliminating the uncertainty of knockout using only one sgRNA scheme, and can ensure gene knockout.

[0081] The applicant declares that the above is only a specific implementation mode of the present invention, but the protection scope of the present invention is not limited thereto. Those skilled in the art should understand that any changes or substitutions that can be easily thought of by those skilled in the art within the technical scope disclosed by the present invention shall fall within the protection scope and disclosure scope of the present invention.

Claims

1. A single plasmid dual sgRNA gene knockout kit, characterized in that: The single-plasmid dual-sgRNA gene knockout kit comprises a first precursor plasmid and a second precursor plasmid, wherein the first precursor plasmid and the second precursor plasmid are digested and connected to obtain a gene knockout plasmid, wherein the gene knockout plasmid contains two sgRNAs and a Cas9 protein expression frame, and the sgRNA comprises a first sgRNA and a second sgRNA.

2. The single-plasmid dual-sgRNA gene knockout kit according to claim 1, characterized in that The first precursor plasmid contains a gRNA scaffold and a U6 promoter, the upstream of the gRNA scaffold contains a first restriction site, and the downstream of the U6 promoter contains a second restriction site; Preferably, the second precursor plasmid contains a U6 promoter, a gRNA scaffold and a Cas9 protein expression frame, the downstream of the U6 promoter contains a third restriction site, and the upstream of the gRNA scaffold contains a fourth restriction site; Preferably, the first restriction enzyme site, the second restriction enzyme site, the third restriction enzyme site and the fourth restriction enzyme site are each independently a restriction enzyme site of any one of BsaⅠ, EcoRI, XhoI or BamHI; Preferably, the first restriction enzyme cutting site is the same as the third restriction enzyme cutting site, and the second restriction enzyme cutting site is the same as the fourth restriction enzyme cutting site; Preferably, the first restriction enzyme cutting site, the second restriction enzyme cutting site, the third restriction enzyme cutting site and the fourth restriction enzyme cutting site are the same.

3. The single-plasmid dual-sgRNA gene knockout kit according to claim 1 or 2, characterized in that The first precursor plasmid contains a replication origin, a gRNA scaffold, a U6 promoter, a resistance gene promoter and a resistance gene along the replication direction, a first restriction site is contained between the replication origin and the gRNA scaffold, and a second restriction site is contained between the U6 promoter and the resistance gene promoter; Preferably, the second precursor plasmid contains a replication origin, a U6 promoter, a gRNA scaffold, a Cas9 protein expression frame, a resistance gene promoter and a resistance gene along the replication direction, and contains a third restriction site and a fourth restriction site between the U6 promoter and the gRNA scaffold.

4. The single-plasmid dual-sgRNA gene knockout kit according to any one of claims 1 to 3, characterized in that The gene knockout plasmid is prepared by the following preparation method: (1) digesting the first precursor plasmid and the second precursor plasmid with restriction endonucleases, respectively, and recovering the digestion products of the first precursor plasmid small fragment and the second precursor plasmid large fragment; (2) Synthesize sgRNA primers and anneal; (3) T4 DNA ligase is used to connect the products of step (1) and step (2) to obtain a gene knockout plasmid.

5. The single-plasmid dual-sgRNA gene knockout kit according to any one of claims 1 to 4, characterized in that The gene knockout plasmid contains a replication origin, a U6 promoter, a first sgRNA, a gRNA scaffold, a U6 promoter, a second sgRNA, a gRNA scaffold and a Cas9 protein expression frame along the replication direction.

6. The single-plasmid dual-sgRNA gene knockout kit according to any one of claims 1 to 5, characterized in that The nucleic acid sequence of the sgRNA includes the sequences shown in SEQ ID NO.1 to SEQ ID NO.

6.

7. The single-plasmid dual-sgRNA gene knockout kit according to any one of claims 1 to 6, characterized in that The gene knockout kit also includes a restriction endonuclease.

8. Use of the single-plasmid dual-sgRNA gene knockout kit according to any one of claims 1 to 7 in gene knockout; Preferably, the gene includes any one of MCM8, HELQ or HUWE1.

9. A dual-target CRISPR / Cas9 gene knockout method, characterized in that: The method comprises knocking out a gene using the single-plasmid dual-sgRNA gene knockout kit according to any one of claims 1 to 7.

10. The method according to claim 9, characterized in that The method specifically includes: enzymatically cutting and connecting the first precursor plasmid and the second precursor plasmid in the single-plasmid dual-sgRNA gene knockout kit to obtain a gene knockout plasmid, introducing the gene knockout plasmid into cells, screening cells with gene editing effects, and verifying the gene knockout effect by molecular biological methods.

Citation Information

Patent Citations

  • Construction method of vector capable of simultaneously expressing two sgRNAs

    CN104388456A

  • Stable knockout single plasmid vector with coordination of transposon and CRISPR / Cas9 system and application of stable knockout single plasmid vector

    CN107686848A

  • Method for constructing MSH2 gene knockout cell line

    CN112501169A

  • Method for constructing MLH1 gene knockout cell line

    CN112501170A

  • Method for performing gene editing on single or multiple genes in cell, and product and use

    WO2022143694A1

Cited By

  • MCM5-Cas9 variant capable of recognizing PAM sequence and application of MCM5-Cas9 variant

    CN119912587A

  • Mcm5-cas9 variant recognizing pam sequence and application thereof

    CN119912587B